Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy

Interleukin-2 can induce an anti-tumour response, but is associated with toxicity. Here, the authors demonstrate that an engineered interleukin-2 promotes intratumoral T regulatory cell depletion while enhancing effective anti-tumour CD8+ T cell responses that result in potent tumor suppression.

Guardado en:
Detalles Bibliográficos
Autores principales: Meenu Sharma, Hiep Khong, Faisal Fa’ak, Salah-Eddine Bentebibel, Louise M. E. Janssen, Brent C. Chesson, Caitlin A. Creasy, Marie-Andrée Forget, Laura Maria S. Kahn, Barbara Pazdrak, Binisha Karki, Yared Hailemichael, Manisha Singh, Christina Vianden, Srinivas Vennam, Uddalak Bharadwaj, David J. Tweardy, Cara Haymaker, Chantale Bernatchez, Shixia Huang, Kimal Rajapakshe, Cristian Coarfa, Michael E. Hurwitz, Mario Sznol, Patrick Hwu, Ute Hoch, Murali Addepalli, Deborah H. Charych, Jonathan Zalevsky, Adi Diab, Willem W. Overwijk
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/ef1801862b2840b0a440db03c657db66
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ef1801862b2840b0a440db03c657db66
record_format dspace
spelling oai:doaj.org-article:ef1801862b2840b0a440db03c657db662021-12-02T17:32:43ZBempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy10.1038/s41467-020-14471-12041-1723https://doaj.org/article/ef1801862b2840b0a440db03c657db662020-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-14471-1https://doaj.org/toc/2041-1723Interleukin-2 can induce an anti-tumour response, but is associated with toxicity. Here, the authors demonstrate that an engineered interleukin-2 promotes intratumoral T regulatory cell depletion while enhancing effective anti-tumour CD8+ T cell responses that result in potent tumor suppression.Meenu SharmaHiep KhongFaisal Fa’akSalah-Eddine BentebibelLouise M. E. JanssenBrent C. ChessonCaitlin A. CreasyMarie-Andrée ForgetLaura Maria S. KahnBarbara PazdrakBinisha KarkiYared HailemichaelManisha SinghChristina ViandenSrinivas VennamUddalak BharadwajDavid J. TweardyCara HaymakerChantale BernatchezShixia HuangKimal RajapaksheCristian CoarfaMichael E. HurwitzMario SznolPatrick HwuUte HochMurali AddepalliDeborah H. CharychJonathan ZalevskyAdi DiabWillem W. OverwijkNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Meenu Sharma
Hiep Khong
Faisal Fa’ak
Salah-Eddine Bentebibel
Louise M. E. Janssen
Brent C. Chesson
Caitlin A. Creasy
Marie-Andrée Forget
Laura Maria S. Kahn
Barbara Pazdrak
Binisha Karki
Yared Hailemichael
Manisha Singh
Christina Vianden
Srinivas Vennam
Uddalak Bharadwaj
David J. Tweardy
Cara Haymaker
Chantale Bernatchez
Shixia Huang
Kimal Rajapakshe
Cristian Coarfa
Michael E. Hurwitz
Mario Sznol
Patrick Hwu
Ute Hoch
Murali Addepalli
Deborah H. Charych
Jonathan Zalevsky
Adi Diab
Willem W. Overwijk
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
description Interleukin-2 can induce an anti-tumour response, but is associated with toxicity. Here, the authors demonstrate that an engineered interleukin-2 promotes intratumoral T regulatory cell depletion while enhancing effective anti-tumour CD8+ T cell responses that result in potent tumor suppression.
format article
author Meenu Sharma
Hiep Khong
Faisal Fa’ak
Salah-Eddine Bentebibel
Louise M. E. Janssen
Brent C. Chesson
Caitlin A. Creasy
Marie-Andrée Forget
Laura Maria S. Kahn
Barbara Pazdrak
Binisha Karki
Yared Hailemichael
Manisha Singh
Christina Vianden
Srinivas Vennam
Uddalak Bharadwaj
David J. Tweardy
Cara Haymaker
Chantale Bernatchez
Shixia Huang
Kimal Rajapakshe
Cristian Coarfa
Michael E. Hurwitz
Mario Sznol
Patrick Hwu
Ute Hoch
Murali Addepalli
Deborah H. Charych
Jonathan Zalevsky
Adi Diab
Willem W. Overwijk
author_facet Meenu Sharma
Hiep Khong
Faisal Fa’ak
Salah-Eddine Bentebibel
Louise M. E. Janssen
Brent C. Chesson
Caitlin A. Creasy
Marie-Andrée Forget
Laura Maria S. Kahn
Barbara Pazdrak
Binisha Karki
Yared Hailemichael
Manisha Singh
Christina Vianden
Srinivas Vennam
Uddalak Bharadwaj
David J. Tweardy
Cara Haymaker
Chantale Bernatchez
Shixia Huang
Kimal Rajapakshe
Cristian Coarfa
Michael E. Hurwitz
Mario Sznol
Patrick Hwu
Ute Hoch
Murali Addepalli
Deborah H. Charych
Jonathan Zalevsky
Adi Diab
Willem W. Overwijk
author_sort Meenu Sharma
title Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
title_short Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
title_full Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
title_fullStr Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
title_full_unstemmed Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
title_sort bempegaldesleukin selectively depletes intratumoral tregs and potentiates t cell-mediated cancer therapy
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/ef1801862b2840b0a440db03c657db66
work_keys_str_mv AT meenusharma bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT hiepkhong bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT faisalfaak bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT salaheddinebentebibel bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT louisemejanssen bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT brentcchesson bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT caitlinacreasy bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT marieandreeforget bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT lauramariaskahn bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT barbarapazdrak bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT binishakarki bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT yaredhailemichael bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT manishasingh bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT christinavianden bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT srinivasvennam bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT uddalakbharadwaj bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT davidjtweardy bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT carahaymaker bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT chantalebernatchez bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT shixiahuang bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT kimalrajapakshe bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT cristiancoarfa bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT michaelehurwitz bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT mariosznol bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT patrickhwu bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT utehoch bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT muraliaddepalli bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT deborahhcharych bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT jonathanzalevsky bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT adidiab bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
AT willemwoverwijk bempegaldesleukinselectivelydepletesintratumoraltregsandpotentiatestcellmediatedcancertherapy
_version_ 1718380220901228544